Sihuan Pharmaceutical (460.HK) - About the Recent Business Adjustments and the Outlook

286 Views29 Nov 2022 08:45
Sihuan's pursuing strategic adjustments actively, but its business transformation may not end up well without persuasive long logic. We recommend buy low and sell high due to Sihuan's characteristics.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x